Safety risks and ethical governance of biomedical applications of synthetic biology
Frontiers in Bioengineering and Biotechnology · 24.10.2023 · 11
DOI: 10.3389/fbioe.2023.1292029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 24.10.2023. Verfasst von Yakun Ou und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Marxism, Huazhong University of Science and Technology, Wuhan, China. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology of the People’s Republic of China.
Abstract (Originalsprache)
Background
In recent years, biomedicine has witnessed rapid advancements in applying synthetic biology. While these advancements have brought numerous benefits to patients, they have also given rise to a series of safety concerns.
Methods
This article provides a succinct overview of the current research on synthetic biology’s application in biomedicine and systematically analyzes the safety risks associated with this field. Based on this analysis, the article proposes fundamental principles for addressing these issues and presents practical recommendations for ethical governance.
Results
This article contends that the primary safety risks associated with the application of synthetic biology in biomedicine include participant safety, biosafety risks, and biosecurity risks. In order to effectively address these risks, it is essential to adhere to the principles of human-centeredness, non-maleficence, sustainability, and reasonable risk control. Guided by these fundamental principles and taking into account China’s specific circumstances, this article presents practical recommendations for ethical governance, which include strengthening ethical review, promoting the development and implementation of relevant policies, improving legal safeguards through top-level design, and enhancing technical capabilities for biocontainment.
Conclusion
As an emerging field of scientific technology, synthetic biology presents numerous safety risks and challenges in its application within biomedicine. In order to address these risks and challenges, it is imperative that appropriate measures be implemented. From a Chinese perspective, the solutions we propose serve not only to advance the domestic development of synthetic biology but also to contribute to its global progress.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Marxism, Huazhong University of Science and Technology, Wuhan, China.
- Center for Bioethics, Huazhong University of Science and Technology, Wuhan, China.
Förderung
- Ministry of Science and Technology of the People’s Republic of China
Zitieren
APA
Ou, Y., & Guo, S. (2023). Safety risks and ethical governance of biomedical applications of synthetic biology. Frontiers in Bioengineering and Biotechnology, 11. https://doi.org/10.3389/fbioe.2023.1292029
Vancouver
Ou Y, Guo S. Safety risks and ethical governance of biomedical applications of synthetic biology. Frontiers in Bioengineering and Biotechnology. 2023;11. doi:10.3389/fbioe.2023.1292029
BibTeX
@article{Ou2023,
author = {Ou, Yakun and Guo, Shengjia},
title = {Safety risks and ethical governance of biomedical applications of synthetic biology},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2023},
volume = {11},
doi = {10.3389/fbioe.2023.1292029}
}
EUVIMED